Ppcw at diagnosis | |||
≤15 mmHg | 16–18 mmHg | p-value | |
Subjects n | 2525 | 239 | |
Age yrs | |||
At enrolment | 53.0±14.0 | 56.1±14.5 | 0.001 |
At diagnosis | 50.1±14.4 | 53.6±14.9 | <0.001 |
Female | 2007 (79.5) | 174 (72.8) | 0.016 |
Time from diagnosis | 24.9 (8.0–50.9) | 20.2 (5.5–44.6) | 0.038 |
6MWD m | 366±126 | 339±117 | 0.004 |
P̄ra mmHg | 9.3±5.6 | 12.8±5.6 | <0.001 |
PVRI Wood units·m2 | 21.1±12.5 | 19.1±13.0 | 0.052 |
Hypertension | 980 (40.2) | 111 (47.6) | 0.023 |
Obese# | 697 (33.3) | 85 (41.9) | 0.014 |
Sleep apnoea | 484 (21.0) | 85 (39.9) | <0.001 |
Diabetes overall | 293 (12.0) | 47 (20.2) | <0.001 |
Renal insufficiency | 109 (4.5) | 25 (10.7) | <0.001 |
Cadiomyopathy dilated | 24 (1.0) | 4 (1.7) | 0.286 |
Warfarin | 1302 (53.4) | 105 (45.1) | 0.016 |
Oxygen | 982 (40.3) | 110 (47.2) | 0.036 |
β-blocker | 296 (12.1) | 51 (21.9) | <0.001 |
Data are presented as mean±sd, n (%) or median (interquartile range), unless otherwise stated. 6MWD: 6-min walk distance; P̄ra: mean right atrial pressure; PVRI: pulmonary vascular resistance index. #: body mass index ≥30 kg·m−2. Reproduced from [15] with permission from the publisher.